June 16, 2024

Digital Pathology Market is Transforming Disease Diagnosis

Pathology is a medical specialty that deals with the diagnosis of disease through the laboratory examination of tissues, cells, and body fluids. Traditionally, this examination involved using microscopes to analyze glass slides. However, digital pathology makes these examinations more efficient by digitizing slides on a computer. It uses high-resolution scanners to convert glass slides into high-quality digital slides that can be examined like virtual slides on screens. This eliminates the need to view slides under a microscope and allows pathologists to consult with colleagues anywhere. Digital pathology offers advantages like remote diagnosis, multi-user access, integrated artificial intelligence, and automated image analysis tools. The ability to share slides globally helps improve diagnostic accuracy and patient care. The growing demand for improved diagnostic accuracy and efficiency across healthcare settings is fueling the digital pathology market.

The Global Digital Pathology Market is estimated to be valued at US$ 994.95 Mn in 2024 and is expected to exhibit a CAGR of 12% over the forecast period from 2024 to 2031.

Key Takeaways
Key players operating in the digital pathology market are Leica Biosystems Nussloch GmbH, Olympus Corporation, F. Hoffmann-La Roche Ltd., Merck KGaA, GE Healthcare, Mikroscan Technologies, Inc., Koninklijke Philips N.V., Sectra AB, Propath UK Limited, Inspirata, Inc., Hamamatsu Photonics, Inc., OracleBio Limited, and MD Biosciences. The major players are focusing on new product launches and mergers & acquisitions to expand their global footprint.

The growing demand for accuracy and efficiency in disease diagnosis is fueling the digital pathology market. Digitization of pathology simplifies consultation, sharing of slides, and integrated AI for improved diagnostics.

Globally, countries are now actively investing in digital health technologies. Penetration of digital pathology is increasing across developed regions of North America and Europe. Meanwhile, Asia Pacific region provides significant growth opportunities due to rising healthcare infrastructure and digitization initiatives by governments in countries like China and India.

Market Key Trends

One of the major trends driving the digital pathology market is the increasing integration of artificial intelligence (AI) and machine learning. AI can analyze digital slides faster and more precisely than humans by automatically detecting features. It helps in tasks like computing tumor proportions, cancer grades, and making preliminary diagnoses. AI integration improves workflow efficiency and diagnostic accuracy of pathologists. As AI and digital technologies continue to advance, their role in pathology is expected to grow significantly over the coming years.

Digital Pathology Market is Transforming Disease Diagnosis Globally with the Adoption of AI-Based Technologies. The transition to digital tools is improving diagnostics and healthcare access.

Porter’s Analysis
Threat of new entrants: The threat of new entrants is moderate as significant capital investment is required to enter the digital pathology market and establish distribution channels. Bargaining power of buyers: The bargaining power of buyers is high as the digital pathology market is fragmented with a large number of global and regional players. Bargaining power of suppliers: Suppliers have low bargaining power due to the intensity of competition in the digital pathology market. Threat of new substitutes: Substitutes present low threat as there are limited product alternatives for digital pathology solutions. Competitive rivalry: Rivalry is high among existing players to gain higher market share through product launches and innovation.

Geographical Regions
North America represented the largest share of the digital pathology market in 2024 owing to substantial healthcare investments, growing adoption of digital platforms, and availability of advanced healthcare facilities. Asia Pacific is projected to be the fastest growing regional market during the forecast period supported by rising healthcare expenditures, increasing awareness regarding digital pathology benefits, and growth of pathology diagnostic infrastructure.

*Note:

  1. Source: Coherent Market Insights, Public sources, Desk research
  2. We have leveraged AI tools to mine information and compile it